InvestorsHub Logo
Followers 5
Posts 201
Boards Moderated 0
Alias Born 09/18/2009

Re: None

Sunday, 03/21/2021 2:04:17 PM

Sunday, March 21, 2021 2:04:17 PM

Post# of 44695
Trying to lay out a bit of simple logic here...

Considering that they approved the inhaled ZYESAMI testing.. and they just announced that the first dosing of inhaled testing has been applied... And....considering that these test are being administered at some of the best and most highly respected facilities in the World, I can draw this possible and highly likely conclusion.

Could it not be concluded that there is absolutely no way they would approve and actually conduct an inhaled ZYESAMI trial if ZYESAMI had not been proven as highly effective for its purpose in the intravenous application of ZYESAMI?

Only my opinion, but if ZYESAMI was not effective in the first intravenous trial, I highly doubt that they would have approved an inhaled ZYESAMI trial.

Seems like that they absolutely know that it is a helpful therapeutic, but they are just trying to see if the application and benefit of ZYESAMI can be simplified and broadened.

Thanks for everyone's opinions and insight as we wait! GLTA!